Generation of a Bama minipig model of hereditary tyrosinemia type III by modifying the Hpd gene
Author:
Affiliation:

(1. Institute of Comparative Medicine & Laboratory Animal Center, Southern Medical University, Guangzhou 510515, China.2. Songshan Lake Pearl Laboratory Animal Science and Technology Ltd., Dongguan 523808.3. Integrated Traditional Chinese and Western Medicine Hospital, Southern Medical University, Guangzhou 510315.4. Wuyi University,Jiangmen 529020)

Clc Number:

R-33

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective To prepare a Bama minipig model of hereditary tyrosinemia type III, thehydroxyphenylpyruvate dioxygenase (Hpd) gene was chosen to be edited by the CRISPR/ Cas9 technology. Methods Templates (used as in vitro transcripts for Cas9 mRNA and sgRNA) were amplified from pST1374-NLS-flag-linker-Cas9and pGL3-U6-gRNA-PGK-puromycin by PCR, respectively, and subsequently transcribed in vitro into Cas9 mRNA andsgRNA-Hpd. Finally, cas9 mRNA and sgRNA-Hpd were co-injected into the cytoplasm of single cell embryos to generatean Hpd-modified Bama minipig. Results Twenty embryos of Bama minipigs co-injected with cas9 mRNA and sgRNA-Hpdwere transplanted into two pseudopregnant mothers. We obtained four offsprings with a modified Hpd gene. Conclusions Inthis study, we have successfully generated Hpd knockout Bama minipigs with hereditary tyrosinemia type III using the CRISPR/ Cas9 technique, which will be a valuable model for research of the tyrosine metabolic pathway.

    Reference
    Related
    Cited by
Get Citation
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:January 26,2019
  • Revised:
  • Adopted:
  • Online: June 05,2019
  • Published: